Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): An intergroup, open-label, randomised phase 3 trial

Additional Metadata
Persistent URL	doi.org/10.1016/S1470-2045(14)71160-X, hdl.handle.net/1765/91130
Journal	The Lancet Oncology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Sternberg, C.N, Skoneczna, I, Kerst, J.M, Albers, P, Fossa, S.D, Agerbaek, M, … Sylvester, R. (2015). Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): An intergroup, open-label, randomised phase 3 trial. The Lancet Oncology, 16(1), 76–86. doi:10.1016/S1470-2045(14)71160-X

Publication